| Genetic effects on gene expression across human tissues GTE Consortium Nature 550 (7675), 204-213, 2017 | 3587* | 2017 |
| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 3229 | 2017 |
| The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2823 | 2015 |
| OncoKB: a precision oncology knowledge base D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ... JCO precision oncology 1, 1-16, 2017 | 2358 | 2017 |
| Comprehensive and integrated genomic characterization of adult soft tissue sarcomas AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ... Cell 171 (4), 950-965, 2017 | 926 | 2017 |
| Integrative analysis identifies four molecular and clinical subsets in uveal melanoma AG Robertson, J Shih, C Yau, EA Gibb, J Oba, KL Mungall, JM Hess, ... Cancer cell 32 (2), 204-220. e15, 2017 | 924 | 2017 |
| The genomic landscape of endocrine-resistant advanced breast cancers P Razavi, MT Chang, G Xu, C Bandlamudi, DS Ross, N Vasan, Y Cai, ... Cancer cell 34 (3), 427-438. e6, 2018 | 913 | 2018 |
| Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity MT Chang, S Asthana, SP Gao, BH Lee, JS Chapman, C Kandoth, JJ Gao, ... Nature biotechnology 34 (2), 155-163, 2016 | 809 | 2016 |
| Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 793 | 2018 |
| Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines K Ellrott, MH Bailey, G Saksena, KR Covington, C Kandoth, C Stewart, ... Cell systems 6 (3), 271-281. e7, 2018 | 727 | 2018 |
| Comprehensive molecular characterization of pheochromocytoma and paraganglioma L Fishbein, I Leshchiner, V Walter, L Danilova, AG Robertson, ... Cancer cell 31 (2), 181-193, 2017 | 723 | 2017 |
| Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies EJ Jordan, HR Kim, ME Arcila, D Barron, D Chakravarty, JJ Gao, ... Cancer discovery 7 (6), 596-609, 2017 | 641 | 2017 |
| A comprehensive pan-cancer molecular study of gynecologic and breast cancers AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ... Cancer cell 33 (4), 690-705. e9, 2018 | 626 | 2018 |
| Genome doubling shapes the evolution and prognosis of advanced cancers CM Bielski, A Zehir, AV Penson, MTA Donoghue, W Chatila, J Armenia, ... Nature genetics 50 (8), 1189-1195, 2018 | 572 | 2018 |
| Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS Z Yao, R Yaeger, VS Rodrik-Outmezguine, A Tao, NM Torres, MT Chang, ... Nature 548 (7666), 234-238, 2017 | 525 | 2017 |
| lncRNA epigenetic landscape analysis identifies EPIC1 as an oncogenic lncRNA that interacts with MYC and promotes cell-cycle progression in cancer Z Wang, B Yang, M Zhang, W Guo, Z Wu, Y Wang, L Jia, S Li, ... Cancer cell 33 (4), 706-720. e9, 2018 | 439 | 2018 |
| Copy number alteration burden predicts prostate cancer relapse H Hieronymus, N Schultz, A Gopalan, BS Carver, MT Chang, Y Xiao, ... Proceedings of the National Academy of Sciences 111 (30), 11139-11144, 2014 | 400 | 2014 |
| Accelerating discovery of functional mutant alleles in cancer MT Chang, TS Bhattarai, AM Schram, CM Bielski, MTA Donoghue, ... Cancer discovery, 2018 | 352 | 2018 |
| The integrated genomic landscape of thymic epithelial tumors M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ... Cancer cell 33 (2), 244-258. e10, 2018 | 344 | 2018 |
| Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma AR Moore, E Ceraudo, JJ Sher, Y Guan, AN Shoushtari, MT Chang, ... Nature genetics 48 (6), 675-680, 2016 | 344 | 2016 |